Endurance Wealth Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $5K | Hold |
165
| – | – | ﹤0.01% | 544 |
|
|
2023
Q1 | $4K | Hold |
165
| – | – | ﹤0.01% | 554 |
|
|
2022
Q4 | $3K | Hold |
165
| – | – | ﹤0.01% | 550 |
|
|
2022
Q3 | $2K | Hold |
165
| – | – | ﹤0.01% | 551 |
|
|
2022
Q2 | $3K | Hold |
165
| – | – | ﹤0.01% | 554 |
|
|
2022
Q1 | $4K | Hold |
165
| – | – | ﹤0.01% | 560 |
|
|
2021
Q4 | $6K | Hold |
165
| – | – | ﹤0.01% | 536 |
|
|
2021
Q3 | $8K | Hold |
165
| – | – | ﹤0.01% | 541 |
|
|
2021
Q2 | $5K | Hold |
165
| – | – | ﹤0.01% | 558 |
|
|
2021
Q1 | $7K | Buy |
+165
| New | +$7K | ﹤0.01% | 555 |
|